Highlights IntegraGen

Equities

ALINT

FR0010908723

Market Closed - Euronext Paris Other stock markets 11:37:11 2024-04-29 am EDT			5-day change	1st Jan Change
0.6 ^EUR	+1.69%		-7.69%	-32.89%

2023	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	IntegraGen SA Announces Revenue Results for the First Half of 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-23	CI
IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-18	CI
IntegraGen SA Reports Earnings Results for the Half Year Ended September 30, 2022	22-10-18	CI
IntegraGen SA Reports Earnings Results for the Half Year Ended September 30, 2022	22-10-18	CI
IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
IntegraGen SA Announces Earnings Result for the First Half of 2021	21-10-08	CI
Global markets live: Intel, Moderna, Burberry, Pfizer, SoftwareOne, Swisscom...	21-07-16
Integragen Sa Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-19	CI
OncoDNA SA completed the acquisition of 64.7% stake in IntegraGen SA for €9.4 million.	20-11-11	CI
Integragen Sa Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-17	CI
IntegraGen : ONCODNA Provides an Update About the Friendly Takeover Bid on INTEGRAGEN	20-08-13	BU
IntegraGen : Agreement to file a friendly takeover bid initiated by ONCODNA on INTEGRAGEN	20-07-09	PU
IntegraGen : Agreement to File a Friendly Takeover Bid Initiated by ONCODNA on INTEGRAGEN to Acquire All Outstanding Shares at a Price of 2.20€ Per Share	20-07-09	BU
OncoDNA SA signed an agreement to acquire IntegraGen SA for €14.5 million.	20-07-08	CI
U.S. Cancer Center to Use IntegraGen's MERCURY™ Cloud-Based Tool for Oncology Sequencing Data Interpretation and Reporting	20-03-26	CI
IntegraGen SA Announces Financial Results for the Half Year Ended June 30, 2018	18-09-19	CI
IntegraGen SA Announces Results of the Ability of miR-31-3p to Predict Response to Therapy for Patients with Metastatic Colorectal Cancer	18-09-04	CI
The SeqOIA Cooperative Health Group Selects Integragen as the Operator of its Sequencing Platform as Part of the France Genomic Medicine 2025 Plan	18-07-31	CI
IntegraGen SA Announces Earnings Results for the Year Ended Dec. 31, 2017; Provides Revenue Guidance for 2018	18-04-12	CI
IntegraGen Presents Positive Data from Liquid Biopsy Studies of Company’s Proprietary miRNAs during 2018 European Lung Cancer Conference	18-04-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights IntegraGen

Equities

ALINT

FR0010908723

Highlights

Filters